RKReza Keikha

Reza Keikha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Reza Keikha has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Jebali

    Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran

    1 shared publication
  • Karim Daliri

    Institute for Neurophysiology, Centre for Physiology and Pathophysiology, Medical Faculty and University Hospital of Cologne, University of Cologne, 50931 Cologne, Germany

    1 shared publication

Latest Publications

  • Open Access

    The Use of Nanobiotechnology in Immunology and Vaccination

    by Reza Keikha, Karim Daliri, Ali Jebali

    Nanotechnology uses the unique properties of nanostructures with a size of 1 to 200 nanometers. Different nanoparticles have shown great promise for the production of new vaccines and drugs. Nanostructures can be used to deliver immunological compounds more effectively than microstructures to target sites. Different nanostructures can be applied to form a new generation of vaccines, adjuvants, and immune system drugs. The goal of nanotechnology is to better respond to a wide range of infectious and non-infectious diseases.